Bicycle Therapeutics plc (50BA) — Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Bicycle Therapeutics plc (50BA) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow (€34.10 Million) in capital expenditures (€277.00K). Check Bicycle Therapeutics plc (50BA) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

€34.10 Million

EUR

Capital Expenditures

€277.00K

EUR

Data as of

Jun 2023

Most recent filing

Annual Capital Reinvestment Ratio for Bicycle Therapeutics plc (None–None)

Year-by-year Capital Reinvestment Ratio for Bicycle Therapeutics plc from None to None. See Bicycle Therapeutics plc (50BA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow